Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Roller, RE; Feichtinger, P.
Thrombosis prophylaxis in geriatric patients].
Z Gerontol Geriatr. 2012; 45(3):231-240
Doi: 10.1007/s00391-012-0294-6
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Roller-Wirnsberger Regina
- Co-authors Med Uni Graz
- Feichtinger Paul
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Older, multimorbid patients carry a high risk of suffering from a thromboembolic disease. The incidence of deep vein thrombosis in the outpatient setting is, depending on age, between 71 and 132 cases per 100,000 inhabitants and year. The rates increase significantly in the hospital setting and with increasing age. Today, pharmacological thrombolytic prophylaxis is the gold standard in patients needing surgical and internal medical care and is described in international evidence-based guidelines. However, the percentage of patients, who despite the guidelines do not receive pharmacological thrombolytic prophylaxis, is still very high. This is especially true for the group of multimorbid, very old patients. In the present work, the pathophysiological and clinical background for the increased susceptibility of thromboembolism in geriatric patients is summarized and the drugs currently available for pharmacological thromboembolic prophylaxis are presented. Hereby, special emphasis is placed on aspects of application in the elderly.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Anticoagulants - therapeutic use
- Female -
- Fibrinolytic Agents - therapeutic use
- Humans -
- Male -
- Thrombosis - drug therapy Thrombosis - prevention & control
- Find related publications in this database (Keywords)
- Venous thromboembolism
- Deep vein thrombosis
- Pulmonary embolism
- Antithrombotic agents
- Geriatric assessment